Europe Hospital Acquired Infections Diagnostics Market Size & Outlook
Europe hospital acquired infections diagnostics market, 2018-2030 (US$M)
Related Markets
Europe hospital acquired infections diagnostics market highlights
- The Europe hospital acquired infections diagnostics market generated a revenue of USD 1,483.6 million in 2024.
- The market is expected to grow at a CAGR of 1.4% from 2025 to 2030.
- In terms of segment, conventional was the largest revenue generating test type in 2024.
- Molecular is the most lucrative test type segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2025 to 2030.
Europe data book summary
| Market revenue in 2024 | USD 1,483.6 million |
| Market revenue in 2030 | USD 1,614.4 million |
| Growth rate | 1.4% (CAGR from 2025 to 2030) |
| Largest segment | Conventional |
| Fastest growing segment | Molecular |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Molecular, Conventional |
| Key market players worldwide | BioMerieux SA, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR, Becton Dickinson & Co, Qiagen NV, Thermo Fisher Scientific Inc, Meridian Bioscience, Hologic, Inc. |
Other key industry trends
- In terms of revenue, Europe region accounted for 34.6% of the global hospital acquired infections diagnostics market in 2024.
- Globally, Europe is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,063.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hospital Acquired Infections Diagnostics Market Scope
Hospital Acquired Infections Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe hospital acquired infections diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hospital acquired infections diagnostics market will help companies and investors design strategic landscapes.
Conventional was the largest segment with a revenue share of 54% in 2024. Horizon Databook has segmented the Europe hospital acquired infections diagnostics market based on molecular, conventional covering the revenue growth of each sub-segment from 2018 to 2030.
The market is driven by the high disease burden, the availability of infrastructure, increased healthcare expenditure, rapid technological advancements, proactive government initiatives, rise in patient awareness, and the presence of major players.
According to an article from the National Center for Biotechnology Information (NCBI), the major subtype of healthcare-associated diseases is urinary tract infections (HTIs). According to the European Centre for Disease Control (ECDC), 4.3 million patients in the European Union/European Economic Area (EU/EEA) are affected by healthcare-associated infections (HAIs) each year.
This data comes from the ECDC's 2022–2023-point prevalence survey, Further, in June 2024, QIAGEN launched 35 new digital PCR assays for microbial applications, enhancing detection of pathogens causing tropical diseases, STIs, and UTIs, expanding its portfolio to over 680 targets for improved infectious disease research.
Reasons to subscribe to Europe hospital acquired infections diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe hospital acquired infections diagnostics market databook
-
Our clientele includes a mix of hospital acquired infections diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe hospital acquired infections diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe hospital acquired infections diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe hospital acquired infections diagnostics market size, by country, 2018-2030 (US$M)
Europe Hospital Acquired Infections Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
